Iterum Therapeutics PLC (ITRM) financials · $38.6M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Iterum Therapeutics PLC (ITRM) $38.6M cap.
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Income | -$18.7M | -$47.5M |
| Net Income | -$24.8M | -$38.4M |
| EPS (Diluted) | -$1.26 | -$2.96 |
| Line | FY2024 | FY2023 |
|---|---|---|
| Total Assets | $44.6M | $26.3M |
| Current Assets | $24.8M | $25.6M |
| Cash & Equivalents | $24.1M | $6.07M |
| Inventory | $0 | $0 |
| PP&E | $23.0K | $51.0K |
| Total Liabilities | $48.7M | $32.7M |
| Current Liabilities | $17.6M | $13.5M |
| Long-term Debt | $31.2M | $11.5M |
| Total Debt | $31.2M† | $11.5M† |
| Shareholders' Equity | -$4.08M | -$6.40M |
| Retained Earnings | -$486.1M | -$461.3M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$26.8M | -$39.3M |
| CapEx | $2.00K | $13.0K |
| Investing Cash Flow | $18.2M | $23.3M |
| Financing Cash Flow | $26.7M | $1.03M |
| Net Change in Cash | $18.1M | -$15.0M |
| Free Cash Flow | -$26.8M | -$39.3M |
FAQ
What is ITRM P/E and revenue?
Iterum Therapeutics PLC (ITRM) $38.6M cap.
What is ITRM revenue?
ITRM income-statement cache has no revenue figure yet.
Is ITRM profitable?
Iterum Therapeutics PLC last cached net income is -$24.8M (FY2024).
What are ITRM total assets?
Iterum Therapeutics PLC last cached total assets are $44.6M (FY2024).
What is ITRM free cash flow?
Iterum Therapeutics PLC last cached free cash flow is -$26.8M (FY2024).
Not investment advice. Cached statements, not a live tape.